; Whereas basic research advances may fuel research and development of new treatments; Whereas there still remain daunting obstacles to the development of new treatments and there are no strategies for screening or early detection of brain tumors; Whereas despite the number of new people diagnosed with a brain tumor every year, and their devastating prognosis, there have only been four FDA-approved drugs and one device to treat brain tumors in the past 30 years; Whereas the four approved drugs for brain tumors have provided only incremental improvements to patient survival, and mortality rates remain little changed over the past 30 years; Whereas there is a need for greater public awareness of brain tumors, including the difficulties associated with research on these tumors and the opportunities for advances in brain tumor research and treatment; and Whereas May 2017, when brain tumor advocates nationwide unite in awareness, outreach, and advocacy activities, would be an appropriate month to recognize as National Brain Tumor Awareness Month : Now, therefore, be it